Regulus Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of drugs that targets microRNAs to treat a range of diseases in the United States. Its product candidates include RG-012, an anti-miR targeting miR-21 that is in Phase II clinical trial for the treatment of Alport syndrome, a life-threatening kidney disease; and RGLS8429, an anti-miR targeting miR-17, which is in Phase 1b clinical study for the treatment of autosomal dominant polycystic kidney disease. The company is also developing a pipeline of preclinical drug products for target organ-selective delivery strategies. Regulus Therapeutics Inc. was incorporated in 2007 and is headquartered in San Diego, California. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of Regulus Therapeutics Inc..
Regulus Therapeutics Inc. business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of Regulus Therapeutics Inc. are also analyzed.
Detailed SWOT Analysis of the company including key strengths and weaknesses of Regulus Therapeutics Inc. , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.
Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.
Financial analysis of Regulus Therapeutics Inc. including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of Regulus Therapeutics Inc. and all latest updates of the company are provided.
The 2025 version of Regulus Therapeutics Inc. report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.
TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 Introduction to the Company
2.1 Regulus Therapeutics Inc.- Key Facts
2.2 Regulus Therapeutics Inc.- Geographic Locations
2.3 Regulus Therapeutics Inc.- Subsidiaries and Affiliates
2.4 Regulus Therapeutics Inc.- Business Divisions
2.5 Regulus Therapeutics Inc.- Key Employees
2.5.1 Management Team
2.5.2 Board of Directors
3. Regulus Therapeutics Inc. Strategic Analysis Review
3.1 Regulus Therapeutics Inc.- Key Strategies
3.2 Regulus Therapeutics Inc.- Company Outlook Statement
3.3 Regulus Therapeutics Inc.- SWOT Analysis
3.3.1 Regulus Therapeutics Inc.- Key Strengths
3.3.2 Regulus Therapeutics Inc.- Key Weaknesses
3.3.3 Regulus Therapeutics Inc.- Potential Opportunities
3.3.4 Regulus Therapeutics Inc.- Potential Threats
3.4 Regulus Therapeutics Inc.- Key Competitors
4. Business Description of the Company
4.1 Regulus Therapeutics Inc.- Business Overview
4.2 Regulus Therapeutics Inc.- Operations by Segment
5 Products and Services Details
5.1 Regulus Therapeutics Inc.- Key Products
5.2 Regulus Therapeutics Inc.- Key Service Areas
5.3 Regulus Therapeutics Inc.- Key Brands
6 Company Developments
6.1 Regulus Therapeutics Inc.- Company History
6.2 Regulus Therapeutics Inc.- Latest Developments
7 Financial Analysis
7.1 Regulus Therapeutics Inc.- Income Statements
7.2 Regulus Therapeutics Inc.- Balance Sheet
7.3 Regulus Therapeutics Inc.- Cash Flow Statements
8 Competitors and Industry Analysis
8.1 Regulus Therapeutics Inc.- Direct Competitors
8.2 Regulus Therapeutics Inc.- Competitor Financial Ratios comparison
8.3 Regulus Therapeutics Inc.- Competitor Stock Charts Comparison
8.4 Regulus Therapeutics Inc.- Industry Analysis
9 Appendix
9.1 About SWOTreports
9.2 Sources and Methodology
9.3 Contact Information
P.S.Financial Analysis will be provided only for companies reporting financial data.
At SWOT Reports, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from SWOT Reports. Experience the caliber of insights that can transform the way you approach your business challenges.
Gain valuable insights into the company for academic or business research purposes with this comprehensive profile. Key elements, such as SWOT analysis and corporate strategy, are included to support your research needs effectively.
Customer and Supplier Identification: Analyze the company’s business structure, operations, major products, services, and strategies to identify potential customers and suppliers.
Leverage a detailed SWOT analysis to understand and evaluate your competitors' business structures, strategies, and core performance metrics. This analysis offers an up-to-date and objective perspective on the company’s strengths, weaknesses, opportunities, and threats.
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!